t
Belluscura plc confirmed the posting of a circular and Notice of General Meeting to shareholders on 31 January 2023. The General Meeting is scheduled for 11:00 on 16 February 2023, at 15 Fetter Lane, London EC1A 4JN.
| Date | 31 Jan 2023 |
| Time | 15:41:39 |
| Category | Miscellaneous |
| ID | 4671O |
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK version of the Market Abuse Regulation (EU) No.596/2014, which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR").
Belluscura plc
("Belluscura", the "Company" or the "Group")
Posting of Circular
Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, confirms that further to its announcement on 27 January 2023, a circular ("the Circular") and Notice of General Meeting has today been posted to shareholders.
General Meeting
The General Meeting will take place at 11.00 on 16 February 2023 at 15 Fetter Lane, London EC1A 4JN.
A copy of the Circular is available from the Company's website : wwww.belluscura.com
For further information please contact:
|
Belluscura plc |
Tel: +44 (0)20 3128 8100 |
|
Adam Reynolds, Chairman Robert Rauker, Chief Executive Officer Anthony Dyer, Chief Financial Officer |
|
|
|
|
|
SPARK Advisory Partners Limited Nominated Adviser |
Tel: +44 (0)20 3368 3550 |
|
Neil Baldwin |
|
|
|
|
|
Dowgate Capital Limited Broker and Bookrunner |
Tel: +44 (0)20 3903 7715 |
|
James Serjeant / Russell Cook |
|
|
|
|
|
MHP Financial PR & Investor Relations |
Tel: +44 (0)20 3128 8100 |
|
Katie Hunt/Peter Lambie/ Matthew Taylor |
email: [email protected] |